
---
title: '券商最新市场研判来了，A股大概率这么走，最看好这些股，两股业绩翻倍（附股）'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202204/W020220410308942031314.png'
author: 证券时报网
comments: false
date: Sun, 10 Apr 2022 08:31:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202204/W020220410308942031314.png'
---

<div>   
<p>券商对4月市场预期整体较为乐观，主流聚焦业绩确定性与稳增长两条主线。</p><p><strong>券商4月市场研判出炉</strong></p><p><strong>聚焦业绩确定性与稳增长主线</strong></p><p></p><p></p><p powered-by="xiumi.us"></p><p></p><p></p><p powered-by="xiumi.us"></p><p>3月市场整体波动较大，A股三大指数均收跌6%以上。申万一级行业方面，仅有煤炭、房地产等5个板块整月录得上涨，电子、有色金属、家用电器等板块跌幅居前。</p><p></p><p>券商对4月市场预期整体较为乐观，主流聚焦业绩确定性与稳增长两条主线。同时机构也提醒市场外围风险扰动仍在，国内趋势反转仍需等待信号。</p><p></p><p>银河证券提示滞涨风险。近期俄乌谈判出现积极信号，但制裁取消之前，供给冲击连锁增加的全球滞涨风险仍不可忽视。5月初美联储第二次加息和缩表计划都大概率落地，美债利率进一步上行对于权益资产的估值压制会比较明显。配置建议关注性价比，关注稳增长和高景气两条主线。</p><p></p><p>部分券商研判市场底。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000686" code="000686">东北证券</a>认为，俄乌冲突可能出现缓解，美联储加息对国内流动性的掣肘在4月也有望缓解。内部经济下行，稳增长政策可能导致流动性宽松，不排除进一步降息降准的可能。整体来看，4月有望延续震荡，出现市场底概率较低，保增长相关行业和部分高景气行业可能偏强。</p><p></p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS601375" code="601375">中原证券</a>表示，国内疫情扩大，3月PMI再次回落到荣枯线下方，未来经济发展势头有待观察。政策底已经出现，下一阶段或寻找市场底，4月市场在阶段性底部震荡的概率较大。</p><p></p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS601788" code="601788">光大证券</a>则提醒关注一季报业绩。其认为，当前市场对于2022年盈利增速预期偏高，全年业绩低预期概率较大，因而在一季报中仍有不错业绩表现的行业股价或将有更好的表现。根据披露1-2月经营数据的公司行业分布来看，食品饮料、医药等消费行业，建筑、建材等稳增长行业或有不错表现。</p><p></p><p>国盛证券也表示，股价表现与一季报业绩高度相关是4月市场的重要特征，而年报业绩与4月个股表现之间的相关性并不显著。预计一季报业绩排名靠前的行业集中于上游资源和高景气赛道板块。</p><p></p><p powered-by="xiumi.us"></p><p></p><p style="text-align: center;"><img class="rich_pages wxw-img" data-galleryid data-ratio="0.5016051364365971" data-s="300,640" src="https://data.stcn.com/djsj/202204/W020220410308942031314.png" data-type="png" data-w="1246" data-imgqrcoded="1" width="500px" height="250.92592592592595px" style="width: 500px; height: 250.92592592592595px;" oldsrc="W020220410308942031314.png" referrerpolicy="no-referrer"></p><p></p><p></p><p powered-by="xiumi.us"></p><p></p><p><strong>券商4月集体推荐这些股</strong></p><p></p><p></p><p powered-by="xiumi.us"></p><p></p><p></p><p powered-by="xiumi.us"></p><p>证券时报·数据宝综合36家券商4月A股市场研判，整理出3家以上券商集体推荐关注个股名单，共计24股上榜。大市值龙头、稳增长以及消费板块依旧获得多家机构青睐。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600519" code="600519">贵州茅台</a>最为瞩目，共进入7家券商4月“金股”组合；<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600941" code="600941">中国移动</a>紧随其后，以6家券商推荐并列第二；<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300861" code="300861">美畅股份</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS601012" code="601012">隆基股份</a>则各成为5家券商的本月“金股”。</p><p></p><p>以个股最新价较机构目标价差额来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>上涨空间居首，目标价是现价的一倍以上；其后<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300861" code="300861">美畅股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS601012" code="601012">隆基股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000519" code="000519">中兵红箭</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600438" code="600438">通威股份</a>上涨空间均突破60%。机构关注度方面，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600519" code="600519">贵州茅台</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300059" code="300059">东方财富</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002142" code="002142">宁波银行</a>最新评级均在30家以上；<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000519" code="000519">中兵红箭</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600975" code="600975">新五丰</a>机构关注不足10家。</p><p></p><p>截至目前，以年报或预告区间中值计算，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600438" code="600438">通威股份</a>全年净利润翻倍。前者由于加大研发投入推陈出新，自主产品与代理产品销售均持续稳步提升；后者则受益于下游需求增长，高纯晶硅产品供不应求，市场价格大幅提升，从而实现盈利大幅提升。其后<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603236" code="603236">移远通信</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300059" code="300059">东方财富</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000519" code="000519">中兵红箭</a>净利润同比70%以上增长。</p><p></p><p>值得注意的是，上述个股中，5股已发布一季度业绩预告。其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600438" code="600438">通威股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000519" code="000519">中兵红箭</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>实现高增长，净利润同比增幅中值依次为496%、168.82%、100%；其余两股<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS601985" code="601985">中国核电</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600519" code="600519">贵州茅台</a>也分别实现55%、19%的业绩增长。（数据宝 张智博）</p><p></p><p></p><p></p><p style="text-align: center;"><img class="rich_pages wxw-img" data-galleryid data-ratio="1.1215415019762847" data-s="300,640" src="https://data.stcn.com/djsj/202204/W020220410308942557395.png" data-type="png" data-w="1012" data-imgqrcoded="1" width="500px" height="560.7707509881424px" style="width: 500px; height: 560.7707509881424px;" oldsrc="W020220410308942557395.png" referrerpolicy="no-referrer"></p><p></p>
  
</div>
            